Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine as Adjuvant to Bupivacaine in Supraclavicular Block for ESRD Patients
NCT05991375Phase 4Completed
- Sponsor
- Sindh Institute of Urology and Transplantation
- Start
- Feb 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dexmedetomidine in pain, sponsored by Sindh Institute of Urology and Transplantation. Started Feb 2021; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pain
Beyond the preview
Go deeper on NCT05991375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05991375.